Bacterial Pathogens of Ventilator Associated Pneumonia in a Tertiary Referral Hospital

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Tuberculosis and respiratory diseases 07/2012; 73(1):32-7. DOI: 10.4046/trd.2012.73.1.32
Source: PubMed


This study evaluates the bacterial pathogens of Ventilator-associated pneumonia (VAP) in a tertiary referral hospital.
A total of 109 bacterial pathogens from 91 adult patients with VAP, who were admitted to the medical intensive care unit from January 2008 to December 2009, were examined. Clinical characteristics, bacterial pathogens, and resistance profiles were analyzed.
Staphylococcus aureus (44%) was the most frequently isolated. Acinetobacter baumanii (30%), Pseudomonas aeruginosa (12%), Stenotrophomonas maltophilia (7%), Klebsiella pneumoniae (6%), and Serratia marcescens (2%) were isolated from the transtracheal aspirates or bronchoalveolar lavage in patients with VAP. There was no significant difference of bacterial pathogens between early and late onset VAP. All isolated S. aureus were methicillin resistant S. aureus; the imipenem resistance rate of A. baumanii was 69%.
The two most frequent pathogens of VAP were S. aureus and A. baumanii. There were no pathogenic differences between early and late onset VAP.

Download full-text


Available from: Yong Soo Kwon, May 02, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ventilator-associated pneumonia (VAP), an infection of the lower respiratory tract which occurs in association with mechanical ventilation, is one of the most common causes of nosocomial infection in the intensive care unit (ICU). VAP causes significant morbidity and mortality in critically ill patients including increased duration of mechanical ventilation, ICU stay and hospitalization. Current knowledge for its prevention, diagnosis and management is therefore important clinically and is the basis for this review. We discuss recent changes in VAP surveillance nomenclature incorporating ventilator-associated conditions and ventilator-associated events, terms recently proposed by the Centers for Disease Control. To the extent possible, we rely predominantly on data from randomized control trials (RCTs) and meta-analyses.
    No preview · Article · Aug 2015 · Current Infectious Disease Reports
  • [Show abstract] [Hide abstract]
    ABSTRACT: La neumonía asociada a la ventilación mecánica es una infección del tracto respiratorio bajo que ocurre en asociación con la ventilación mecánica, y es una de las causas más comunes de infección nosocomial en la unidad de cuidado intensivo (UCI). Es, a su vez, una causa importante de morbimortalidad en pacientes críticamente enfermos, en términos de prolongación de la ventilación mecánica, la estancia en la UCI y la hospitalización. En esta revisión se discuten los cambios recientes en la nomenclatura empleada en la vigilancia de la neumonía asociada a la ventilación mecánica, en la cual se incluyen condiciones y eventos asociados al ventilador, términos propuestos recientemente por el Centro de Control de Enfermedades de Estados Unidos. En la medida de lo posible, se hizo con base en informaciones obtenidas en estudios aleatorizados controlados y metaanálisis.
    No preview · Article · Oct 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several guidelines base the empirical therapy of ventilator-associated pneumonia (VAP) on the time of onset. However, there is emerging evidence that the isolated microorganisms may be similar regardless of onset time. This study evaluated the characteristics and outcomes of VAP with different onset times. All of the mechanically ventilated patients admitted to the ICU of a 900-bed tertiary-care hospital between 01/08/2003 and 31/12/2010 were prospectively followed for VAP development according to the National Healthcare Safety Network criteria. The patients were categorized into four groups: EO if VAP occurred within 4 days of intubation and hospital admission; LO if VAP occurred after 4 days of admission; EL if VAP occurred within 4 days of intubation, but after the fourth hospitalization day; and LL if VAP occurred after the fourth day of intubation and hospitalization. Out of the 394 VAP episodes, 63 (16%) were EO episodes, 331 (84.0%) were LO episodes, 40 (10.1%) were EL episodes and 291 (73.1%) were LL episodes. The isolated microorganisms were comparable among the four groups, with a similar rate of potentially multidrug resistant organisms in the EO-VAP (31.7%), LO-VAP (40.8%), EL-VAP (37.5%) and LL-VAP (43.3%) samples. The hospital mortality was 24% for EO-VAP cases, 28% for LO-VAP cases, 40% for EL-VAP cases and 49% for LL-VAP cases. However, in the adjusted multivariate analysis, neither LO-VAP, EL-VAP nor LL-VAP was associated with an increased risk of hospital mortality compared with EO-VAP (OR, 0.86 95% CI, 0.34-2.19; 1.22; 95% CI, 0.41-3.68, and 0.95; 95% CI, 0.43-2.10, respectively). In this study, the occurrence of potential multidrug resistant pathogens and the mortality risk were similar regardless of VAP timing from hospital admission and intubation. The bacterial isolates obtained from the VAP cases did not follow an early vs. late-onset pattern, and thus, these terms may not be clinically helpful.
    Full-text · Article · Oct 2015